Power Up Your Morning with iBIO NewsBrief!
Get the daily email that keeps you informed and connected in the life sciences industry
📲 READ THE LATEST NEWSLETTER
iBIO IN THE NEWS
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PRESS RELEASES AND BLOGS
Illinois Biotechnology Innovation Organization Elects New Board Chair and Adds New Board Members
iBIO NewsBrief Short: Get to Know Dr. Ken Johnson, the New Chair of the iBIO Board
IBIO Member December Grant Report from G2G Consulting
iBIO Announces Donation to Support Annual Timothy P. Walbert Entrepreneurship Impact Award
MEMBER NEWS
Biopharma Sector Experiences Shift in Venture Funding and Investment Trends in Q1 2024
Abbott Receives FDA Clearance for Lingo, an Over-the-Counter Glucose Monitor
Formosa Laboratories Expands North American Presence with Acquisition of Suburban Chicago-Based SynChem
The Future of Bioelectronics: Living Cells and Electronics Unite
POLICY NEWS
House Democrats’ Drug Pricing Plan Would Be Bad Medicine for Governor Pritzker’s Economic Plan for Illinois
Tell Congress Doctors, Not Bureaucrats, Should Decide What Medicines Americans Receive
iBIO Opposes New Drug Pricing Bill from House Democrats Leadership
Op-ed: Illinois is running out of lab space
ALL NEWS
Illinois Endotronix Acquired by Edwards Lifesciences in Major Healthcare Deal
In a significant development for Illinois' healthcare technology sector, Endotronix has been...
UChicago and Orange Grove Bio Partner to Boost Chicago’s Biotech Ecosystem
The University of Chicago's Polsky Center for Entrepreneurship and Innovation has forged a...
Chicago-based Valinor Pharma Acquired by Grünenthal in $250 Million Deal
Valinor Pharma, LLC ("Valinor") has announced its acquisition by Grünenthal in an all-stock deal...
Biotech’s Resurgence: A Mid-2024 Industry Pulse Check
The biotech sector has experienced a remarkable turnaround in 2024, with the SPDR S&P Biotech...
Meitheal Pharmaceuticals Acquires Rights to Novel Antibiotic CONTEPO™
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals...